The SARS-CoV-2 N Protein Is a Good Component in a Vaccine-Reference-Cited by-同舟云学术

The SARS-CoV-2 N Protein Is a Good Component in a Vaccine

Published:2020-08-31 Issue:18 Volume:94 Page:
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:J Virol

Author:

Ahlén Gustaf¹,Frelin Lars¹^ORCID,Nikouyan Negin¹,Weber Friedemann²^ORCID,Höglund Urban³,Larsson Olivia³,Westman Marie⁴,Tuvesson Ola⁵,Gidlund Eva-karin⁵,Cadossi Matteo⁶,Appelberg Sofia⁷,Mirazimi Ali¹⁷,Sällberg Matti¹

Affiliation:

1. Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Stockholm, Sweden

2. Justus Liebig University Giessen, Giessen, Germany

3. Adlego Biomedical AB, Uppsala, Sweden

4. Karolinska Trial Alliance, Karolinska University Hospital, Stockholm, Sweden

5. Cobra Biologics, Matfors, Sweden

6. IGEA Spa, Carpi, Italy

7. Public Health Agency of Sweden, Solna, Sweden

Funder

Vetenskapsrådet

Region Stockholm

EU | Horizon 2020 Framework Programme

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/JVI.01279-20

Reference8 articles.

1. The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development

2. Protection against hepatitis B virus infection by immunization with hepatitis B core antigen

3. SARS-CoV-2 infection protects against rechallenge in rhesus macaques

4. Development of an inactivated vaccine candidate for SARS-CoV-2

5. van Doremalen N Lambe T Spencer A Belij-Rammerstorfer S Purushotham JN Port JR Avanzato V Bushmaker T Flaxman A Ulaszewska M Feldmann F Allen ER Sharpe H Schulz J Holbrook M Okumura A Meade-White K Perez-Perez L Bissett C Gilbride C Williamson BN Rosenke R Long D Ishwarbhai A Kailath R Rose L Morris S Powers C Lovaglio J Hanley PW Scott D Saturday G de Wit E Gilbert SC Munster VJ. 2020. ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques. bioRxiv doi:10.1101/2020.05.13.093195.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction and immune effect evaluation of the S protein heptad repeat-based nanoparticle vaccine against porcine epidemic diarrhea virus;Virology;2024-08

2. Evaluation of an RBD-nucleocapsid fusion protein as a booster candidate for COVID-19 vaccine;iScience;2024-07

3. Combination of S1–N–Terminal and S1–C–Terminal Domain Antigens Targeting Double Receptor-Binding Domains Bolsters Protective Immunity of a Nanoparticle Vaccine against Porcine Epidemic Diarrhea Virus;ACS Nano;2024-05-02

4. The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality;Viruses;2024-03-08

5. Toward a SARS-CoV-2 VLP Vaccine: HBc/G as a Carrier for SARS-CoV-2 Spike RBM and Nucleocapsid Protein-Derived Peptides;Vaccines;2024-03-04